Dozens of state attorneys general are urging Congress to pass a law prohibiting PBMs from simultaneously owning pharmacies, arguing such a move would boost competition and create more affordable prescription drug prices for Americans. Their concern is these arrangements create conflicts of interest that allow PBMs to dominate the design of health plans for tens of millions of Americans, and also distort the distribution and pricing for prescription medicines.
